Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation
Clinical trial NCT07656376 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07656376
- Sponsor
- Jiangxi Kvvit Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-06-06
- Primary completion
- 2029-02-07
- Enrollment
- 465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.